Caisse de Depot et Placement du Quebec (CDPQ)’s Royalty Pharma RPRX Stock Holding History

Caisse de Depot et Placement du Quebec (CDPQ)’s Portfolio RPRX Stock Details RPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$10.5M	Sell	218,031 -693,654	-76%	-$30.4M	0.02%	429
2025 Q4	$35.2M	Buy	911,685 +643,985	+241%	+$24.6M	0.06%	292
2025 Q3	$9.44M	Buy	267,700 +189,373	+242%	+$6.86M	0.02%	396
2025 Q2	$2.82M	Sell	78,327 -653,074	-89%	-$21.6M	0.01%	432
2025 Q1	$22.8M	Buy	731,401 +18,616	+3%	+$590K	0.05%	300
2024 Q4	$18.2M	Buy	+712,785	New	+$18.9M	0.04%	298
2024 Q2	–	Sell	-92,452	Closed	-$2.81M	–	534
2024 Q1	$2.81M	Buy	+92,452	New	+$2.73M	0.01%	410
2023 Q2	–	Sell	-71,400	Closed	-$2.57M	–	540
2023 Q1	$2.57M	Buy	+71,400	New	+$2.65M	0.01%	446
2021 Q2	–	Sell	-18,989	Closed	-$828K	–	674
2021 Q1	$828K	Buy	+18,989	New	+$900K	﹤0.01%	567

Other funds holding RPRX

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Caisse de Depot et Placement du Quebec (CDPQ)'s RPRX Position: Q1 2026 in Review

Caisse de Depot et Placement du Quebec (CDPQ) reduced its Royalty Pharma (RPRX) stake by 76% in Q1 2026, selling an estimated $30.4M and leaving 218,031 shares worth $10.5M. The position accounts for 0.02% of the portfolio, ranked #429.

Caisse de Depot et Placement du Quebec (CDPQ) first reported a position in RPRX in Q1 2021 and has held it in 9 quarters since. The position peaked at $35.2M in Q4 2025. 590 funds tracked by Wall St. Rank hold RPRX as of Q1 2026.

Caisse de Depot et Placement du Quebec (CDPQ) held 218,031 shares of Royalty Pharma worth $10.5M as of Q1 2026.
Caisse de Depot et Placement du Quebec (CDPQ) sold 693,654 Royalty Pharma shares in Q1 2026, an estimated $30.4M.
Royalty Pharma made up 0.02% of Caisse de Depot et Placement du Quebec (CDPQ)'s portfolio in Q1 2026, its #429 holding.
Caisse de Depot et Placement du Quebec (CDPQ) first reported a position in Royalty Pharma in Q1 2021 and has held it in 9 quarters since.
Caisse de Depot et Placement du Quebec (CDPQ)'s Royalty Pharma position peaked at $35.2M in Q4 2025.
590 funds tracked by Wall St. Rank held Royalty Pharma as of Q1 2026.

Based on Caisse de Depot et Placement du Quebec (CDPQ)'s 13F filing for Q1 2026, filed 14 May 2026.